Sanofi Was Mystery Bidder That Lost Reata to Biogen
Biogen Inc. narrowly beat out Sanofi SA to clinch its $7.3 billion acquisition of Reata Pharmaceuticals, according to
1970-01-01 08:00
Hedge Funds Turned Long Aussie Dollar at Just the Wrong Time
Hedge funds turned the most bullish on the Australian dollar than they’ve been at any point this year,
1970-01-01 08:00
China’s Economic Woes Deepen With Housing Market Slump
China’s economy is showing little sign of a rebound, with fresh stress in the property market and deflation
1970-01-01 08:00
Yellow Sees Even More Interest From Lenders for Bankruptcy Financing
Yellow Corp. has drawn additional interest from potential financiers who are offering alternative bankruptcy financing for the short-haul
1970-01-01 08:00
Sliding Aussie Seen Stoking Prices as Shock-Absorber Fades
Australia’s depreciating currency, historically a boon for the world’s 12th largest economy, appears more likely to fuel inflation
1970-01-01 08:00
RBA’s Lowe Keeps Door Open to Further Hike, Eyes Services Prices
Australia’s central bank is keeping its options open on further policy tightening as it studies which way services
1970-01-01 08:00
Tainted Medication Fears Spur US Defense Department to Seek Outside Testing
The US Department of Defense entered an agreement with Valisure, an independent lab that’s spotted dangerous chemicals in
1970-01-01 08:00
A $2.8 Million Miracle Therapy Eludes Some Long-Suffering Patients
Liany Benedi long dreamed of a cure for the disease that has shadowed her since she was 2
1970-01-01 08:00
Australian Consumer Sentiment Slips as Price Pressures Mount
Australia’s consumer confidence slipped further into “deeply pessimistic” territory as elevated inflation combined with high interest rates intensifies
1970-01-01 08:00
Elon Musk's Neuralink Raises $280 Million to Develop Brain Implants
Neuralink Corp., Elon Musk’s brain-implant company, has raised $280 million in new funding from investors to develop its
1970-01-01 08:00
Sage Tumbles as Depression Pill Approval Omits Major Disorder
Sage Therapeutics Inc. slumped in early trading after regulators granted approval to its fast-acting pill only for postpartum
1970-01-01 08:00
Astellas Pharma Secures US FDA Approval for Izervay
The US Food and Drug Administration approved Astellas Pharma Inc.’s Izervay for the treatment of age-related macular degeneration,
1970-01-01 08:00